Enjoy complimentary customisation on priority with our Enterprise License!
The CMO market share in the pharmaceutical industry is expected to increase by USD 46.69 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 7.41%.
This CMO market research report of pharmaceutical industry provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers CMO market segmentation in the pharmaceutical industry by service (API manufacturing service and FDF manufacturing service) and geography (Europe, North America, APAC, MEA, and South America). The CMO market report of pharmaceutical industry also offers information on several market vendors, including Almac Group Ltd., Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Ltd., CMIC HOLDINGS Co. LTD., Curia Inc., Dr. Reddys Laboratories Ltd., Lonza Group Ltd., Lupin Ltd., Pfizer Inc., and Thermo Fisher Scientific Inc. among others.
Download the Free Report Sample to Unlock the CMO Market in Pharmaceutical Industry Size for the Forecast Period and Other Important Statistics
The availability of cost-efficient resources in emerging markets is notably driving the CMO market growth in pharmaceutical industry, although factors such as the stereotypical nature of CMOs may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the CMO market in the pharmaceutical industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key CMO Market Driver In Pharmaceutical Industry
One of the key factors driving growth in the CMO market in the pharmaceutical industry is the availability of cost-efficient resources in emerging markets. Countries such as China, India, Brazil, and Mexico have witnessed significant advances in their healthcare infrastructure and technological advances in their drug development processes. As a result, large and medium-sized pharmaceutical companies from developed countries are outsourcing various drugs and therapies' research and manufacturing operations to the vendors in such countries. One of the key reasons for the increasing popularity of outsourcing these processes is the availability of labor at a comparatively lower price than in developed countries. Factors such as the increasing number of US Food and Drugs Association (FDA)-approved manufacturing plants in such countries also encourage outsourcing. Therefore, the global CMO market in the pharmaceutical industry is expected to grow strongly during the forecast period.
Key CMO Market Challenge In Pharmaceutical Industry
The stereotypical nature of CMOs will be a major challenge for the CMO market in pharmaceutical industry during the forecast period. Despite the growing popularity of CMOs in emerging countries such as China and India, the global CMO market in the pharmaceutical industry faces a significant challenge due to the limited offerings of the CMOs vendors. CMOs in Asia, which holds the highest share of the global CMO market in the pharmaceutical industry, lack access to advanced technologies. CMOs in the region primarily manufacture small molecule-based drugs, which can be produced in large quantities. This is mainly due to the complex manufacturing processes of biological drugs, which require advanced technologies. The cost of manufacturing such drugs is also usually high. Many global CMOs operate on a small scale and they lack the funding required to produce biological drugs on a large scale. As a result, the growth opportunity for the small and medium-sized CMOs is restricted to the growth of small molecule-based generic drugs. This is currently a significant challenge faced by CMOs and is expected to hinder the growth of the global CMO market in the pharmaceutical industry.
This CMO market analysis report of pharmaceutical industry also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the CMO market in pharmaceutical industry encompasses successful business strategies deployed by the key vendors. The CMO market in the pharmaceutical industry is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The CMO market forecast report of pharmaceutical industry offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
For more insights on the market share of various regions Request for a FREE sample now!
35% of the market's growth will originate from Europe during the forecast period. Germany, France, and the UK are the key markets for CMO in the pharmaceutical industry in Europe. However, the market growth rate in this region will be slower than the growth of the market in the North American, MEA, and APAC regions.
Various small- and medium-sized CMOs are working on offering efficient services at a low cost to pharmaceutical companies by cutting down overhead costs. This will facilitate the CMO market growth in pharmaceutical industry in Europe over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
To gain further insights on the market contribution of various segments Request for a FREE sample
The CMO market share growth in the pharmaceutical industry by the API manufacturing service segment will be significant during the forecast period. The growing collaborations between global pharmaceutical companies and API manufacturers such as CMOs, particularly in India and China, are the driving force behind the segment's growth. The growing interest of large pharmaceutical companies to capitalize on Indian and Chinese strengths of bulk production yields (high volumes at low cost) is another major force driving the growth of the segment.
This report provides an accurate prediction of the contribution of all the segments to the growth of the CMO market size in pharmaceutical industry and actionable market insights on post COVID-19 impact on each segment.
CMO Market Scope in Pharmaceutical Industry |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7.41% |
Market growth 2022-2026 |
$ 46.69 billion |
Market structure |
Fragmented |
YoY growth (%) |
7.92 |
Regional analysis |
Europe, North America, APAC, MEA, and South America |
Performing market contribution |
Europe at 35% |
Key consumer countries |
US, Germany, China, France, and UK |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
Almac Group Ltd., Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Ltd., CMIC HOLDINGS Co. LTD., Curia Inc., Dr. Reddys Laboratories Ltd., Lonza Group Ltd., Lupin Ltd., Pfizer Inc., and Thermo Fisher Scientific Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Service
Customer landscape
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.